Group 1 - Huntsman shares are yielding above 9% based on its quarterly dividend, with the stock trading as low as $10.98 [1] - Historically, dividends have contributed significantly to the total return of the stock market, exemplified by the iShares Russell 3000 ETF, which saw a 0.6% decrease in share price over twelve years but provided $10.77 per share in dividends, resulting in a total return of 13.15% [1] - Collecting a yield above 9% is considered attractive if sustainable, especially when compared to the average annual total return of about 1.0% from reinvested dividends [1] Group 2 - Dividend amounts are unpredictable and typically fluctuate with company profitability, making historical performance important for assessing future dividend sustainability [2]

Company Overview - GeneDx Holdings Corp. is a biotechnology company that specializes in clinical diagnostic services for rare and pediatric genetic disorders [3]. Allegations of Wrongdoing - Grizzly Research published a report on February 5, 2025, alleging that GeneDx is committing widespread fraud, claiming that the company's growth is largely an illusion driven by fraudulent schemes aimed at exploiting Medicaid and Medicare systems to artificially inflate revenue [4]. - The report accuses GeneDx of using an illegal practice known as "code stacking" to inflate its revenue [4]. - It is suggested that GeneDx executives, including CEO Katherine Stueland and CFO Kevin Feeley, may be aware of imminent risks, as they have consistently sold their shares immediately upon vesting without engaging in open market purchases [4]. Stock Market Reaction - Following the publication of the report, GeneDx's stock price fell by $4.84 per share, or 6.72%, closing at $67.18 per share on February 5, 2025 [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Avis Budget Group, Inc. securities during the specified class period of the upcoming lead plaintiff deadline for a class action lawsuit [1][2]. Group 1: Class Action Details - The class period for the lawsuit is from February 16, 2024, to February 10, 2025, and investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the court to serve as lead plaintiff by June 24, 2025 [2]. Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time and being ranked No. 1 for the number of settlements in 2017 [3]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [3]. Group 3: Case Allegations - The lawsuit alleges that during the class period, Avis Budget made false and misleading statements regarding its fleet rotation plan, which significantly shortened the useful life of its vehicles and led to billions in impairment charges [4]. - The allegations suggest that these misstatements had a significant negative impact on Avis Budget's financial results and overstated its business prospects [4].

I give a buy rating for Five Below (NASDAQ: FIVE ) as I believe the business has successfully turned the corner, with Q1'25 showing clear evidence of it. With management regaining confidence in scaling the footprint and with valuationsI’m a fundamental, valuation-driven investor with a strong focus on identifying businesses that have the potential to scale over time and unlock massive terminal value. My investment approach centers around understanding the core economics of a business—its competitive moat, u ...

SOUTH SAN FRANCISCO, Calif., June 13, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, today held its Annual Meeting of Stockholders (the “Annual Meeting”) in a virtual-only format. Preliminary results from the Annual Meeting indicate that two proposals were approved and two proposals were rejected by Vaxart stockholders. Stockholders voted ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased NET Power Inc. securities between June 9, 2023, and March 7, 2025, of the upcoming lead plaintiff deadline on June 17, 2025, for a class action lawsuit [1] Group 1: Class Action Details - Investors who bought NET Power securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by June 17, 2025 [2] - The lawsuit alleges that NET Power made false and misleading statements regarding Project Permian, including the likelihood of project completion on schedule and the associated costs [3] Group 2: Allegations Against NET Power - The lawsuit claims that NET Power was unlikely to complete Project Permian on time and that the project would be significantly more expensive due to supply chain issues and site-specific challenges [3] - Defendants' projections regarding the time and capital needed for Project Permian were deemed unrealistic, which could negatively impact NET Power's business and financial results [3] - The public statements made by the defendants were materially false and misleading, leading to investor damages when the true details became known [3] Group 3: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4] - The firm has achieved significant settlements, including the largest securities class action settlement against a Chinese company at the time, and has recovered hundreds of millions of dollars for investors [4] - In 2019, the firm secured over $438 million for investors, and its founding partner was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020 [4]

About this content About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa for leading trade publications. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government ...

Core Viewpoint - Civitas Resources, Inc. is facing a class action lawsuit due to alleged misleading statements regarding its oil production and financial condition during the class period from February 27, 2024, to February 24, 2025 [1][3]. Group 1: Class Action Details - The lead plaintiff deadline for the Civitas Resources class action is set for July 1, 2025 [1][2]. - Investors who purchased Civitas securities during the class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1][2]. Group 2: Allegations Against Civitas Resources - The lawsuit claims that Civitas was likely to significantly reduce its oil production in 2025 due to declines following a production peak in Q4 2024 and low TIL count at the end of 2024 [3]. - Increasing oil production would necessitate acquiring additional acreage and development locations, leading to significant debt and potential asset sales [3]. - The company's financial condition would require disruptive cost-reduction measures, including a significant workforce reduction [3]. - Civitas's business and financial prospects, as well as operational capabilities, were allegedly overstated, making public statements false and misleading [3]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time [4]. - The firm was ranked No. 1 by ISS Securities Class Action Services for the number of securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013 [4]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering significant amounts for clients [4].

Shares of tech giant Oracle (ORCL 7.84%) rallied another 7.8% on Friday, even as the broader Nasdaq Composite was down 1.3% on the day.The notable and divergent outperformance came after a series of sell-side analyst upgrades in the aftermath of Wednesday's blowout earnings report.Analysts race to upgrade Oracle's price targetIn Wednesday's fiscal fourth-quarter 2025 report, Oracle posted 11% revenue growth to $15.9 billion, while adjusted (non-GAAP) earnings per share (EPS) rose a more modest 4.3%. Still, ...

Group 1 - Oracle has appointed two new presidents, Clay Magouyrk and Michael Sicilia, as part of a succession plan for co-founder Larry Ellison [1][2] - Magouyrk, who has a background as a former Amazon software development engineer, has rapidly ascended within Oracle since joining in 2014 and currently oversees Oracle Cloud Infrastructure [3] - Sicilia is the executive vice president of Oracle Industries and has been leading the company's acquisition of Cerner [3] Group 2 - The new executives are expected to help Oracle gain traction in the cloud-computing market, which has seen Oracle shares reach a record high after beating analyst estimates and raising revenue forecasts [4] - Analysts from Piper Sandler noted that Oracle has entered a new wave of enterprise popularity reminiscent of the late 1990s Internet era [4]